WebCompanies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. WebMar 13, 2024 · Cingulate recently announced the initiation of its first Phase 3 trial for CTx-1301, an adult dose-optimization efficacy and safety study to assess onset and duration, with results expected in the third quarter of 2024. In addition, the Company plans to initiate its pivotal Phase 3 trial, a fixed-dose, placebo-controlled study in pediatric and ...
Cingulate and Indegene Announce Joint Commercialization …
WebCingulate Inc Stock Forecast - Simple Moving Average. Stocks . USA . Stock . Cingulate Inc WT. Summary; Performance; Fundamentals; Advice; Performance History Market Value Patterns Correlation Forecast. CINGW. Stock : USD 0.20 0.06 23.08% : Cingulate Stock Forecast is based on your current time horizon. WebMar 27, 2024 · Cingulate Inc (CING) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Cingulate Inc lowest stock price was $0.66 and its highest was $2.14 in the past 12 months. What is Cingulate Inc’s market cap? Currently, no data Available. ... sport clips rocklin
Cingulate Inc. Announces Pricing of $25.0 Million Initial
WebCING Stock 12 Months Forecast. $4.25. (308.65% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Cingulate Inc in the last 3 months. The average price … WebFind real-time CING - Cingulate Inc stock quotes, company profile, news and forecasts from CNN Business. WebApr 5, 2024 · It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Sector Health Care. Industry Pharmaceuticals. Employees 15. Founded 2012. Website www.cingulate.com. Address 1901 West 47th Place , Kansas City, United States. sportclips rosenberg